These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 599084)

  • 1. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
    Monif GR; Clark PR; Shuster JJ; Baer H
    Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD; Levison ME; Kaye D
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.
    Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH; Jones RN
    J Antibiot (Tokyo); 1977 Dec; 30(12):1098-106. PubMed ID: 599083
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of Ro 13-9904.
    Hinkle AM; Bodey GP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):574-8. PubMed ID: 6778383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ticarcillin, carbenicillin and ampicillin against some gram-negative bacilli.
    Legakis NJ; Papavassiliou J
    J Antibiot (Tokyo); 1975 Nov; 28(11):912-9. PubMed ID: 811636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Oct; 14(4):549-52. PubMed ID: 102245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents.
    Henderson DK; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1977 Apr; 11(4):679-82. PubMed ID: 856019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.
    Fuchs PC; Gavan TL; Gerlach EH; Jones RN; Barry AL; Thornsberry C
    Am J Med Sci; 1977; 274(3):255-63. PubMed ID: 610415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].
    Marklein G; Häfelein J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):40-53. PubMed ID: 6277101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.
    White GW; Malow JB; Zimelis VM; Pahlavanzadeh H; Panwalker AP; Jackson GG
    Antimicrob Agents Chemother; 1979 Apr; 15(4):540-3. PubMed ID: 111616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.